Medication info

Anguk Telmisartan 80/12.5 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Anguk Pharmaceutical Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
30 tablets/box [10 tablets/Alu-Alu*3]
Approval status
Expired

MFDS item code 202004034 · Approved 2020.05.29

This product's status changed to Expired on 2025.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take this medicine once daily with a beverage, with or without food. Before switching to this medicine, which contains fixed doses of each ingredient, it is recommended that the dose of each ingredient be individually titrated. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance <30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dosage adjustment is required.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Anguk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension, particularly when blood pressure is not adequately controlled with monotherapy of telmisartan and additional administration is required for more effective blood pressure management.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take this medicine once daily with a beverage, with or without food. Before switching to this medicine, which contains fixed doses of each ingredient, it is recommended that the dose of each ingredient be individually titrated. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance <30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dosage adjustment is required.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it may cause serious problems to the fetus or newborn. Patients with allergies to any components of this medication or those with certain liver or kidney diseases should not take it. Precaution is necessary for the elderly or patients with high potassium levels in the blood or poor liver function when taking this medication. The hydrochlorothiazide component may increase sensitivity to sunlight, raising the risk of skin cancer, thus avoiding sun exposure and regularly checking skin condition is advised. Various side effects, such as hypotension, dizziness, dyspepsia, and skin rash may occur; if symptoms are severe, immediate consultation with a healthcare professional is required. Particular attention should be paid to rapid drops in blood pressure when starting or changing the dosage of the medication. This medication may interact with other antihypertensives, diuretics, or potassium supplements, so it is essential to inform prescribers of any other medications being taken. Women who are pregnant, planning to become pregnant, or breastfeeding should not use this medication and should switch to other safe medications if necessary. In case of overdose, hypotension, electrolyte imbalances, or dehydration may occur, requiring immediate medical attention. This medication is not recommended for children under 18 years of age, as safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorder
Show 110 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • difficulty breathing
  • respiratory pain
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disease
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased serum uric acid
  • increased serum creatinine
  • increased creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • bile stasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal dysfunction
  • weakness
  • fever
  • nausea
  • abdominal pain
  • gastrointestinal bleeding
  • esophagitis
  • dyspepsia
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • anxiety
  • proteinuria
  • rash
  • itching
  • myalgia
  • feeling of floating
  • tremor of lips and hands
  • heightened sensitivity
  • decreased vision
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the medication's effectiveness.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.